Skip to content

Replimune Group REPL FX Effect on Cash

FX Effect on Cash at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$900K-250%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$122K+1,320%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
-$988K
Summit Therapeutics logo
Summit TherapeuticsSMMT
-$19K-150%
Roivant Sciences logo
Roivant SciencesROIV
$1.32M
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$0+100%

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's FX effect on cash?
Replimune Group (REPL) reported FX effect on cash of $1.04M in Q4 2025.
How has Replimune Group's FX effect on cash changed year-over-year?
Replimune Group's FX effect on cash increased by 786.1% year-over-year, from -$151K to $1.04M.
What is the long-term trend for Replimune Group's FX effect on cash?
Over 3 years (2022 to 2025), Replimune Group's FX effect on cash has grown at a -27.2% compound annual growth rate (CAGR), from $818K to $315K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.